The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.
Read More…
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees7,000
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable
Chemours (NYSE:CC) Frequently Asked Questions
What is Chemours' stock symbol?
Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."
How often does Chemours pay dividends? What is the dividend yield for Chemours?
Chemours declared a quarterly dividend on Wednesday, February 12th. Stockholders of record on Thursday, February 27th will be paid a dividend of $0.25 per share on Monday, March 16th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.16%. The ex-dividend date of this dividend is Wednesday, February 26th. View Chemours' Dividend History.
How were Chemours' earnings last quarter?
Chemours Co (NYSE:CC) issued its earnings results on Thursday, February, 13th. The specialty chemicals company reported $0.56 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.42 by $0.14. The specialty chemicals company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. View Chemours' Earnings History.
When is Chemours' next earnings date?
What guidance has Chemours issued on next quarter's earnings?
Chemours updated its FY20 earnings guidance on Thursday, February, 13th. The company provided EPS guidance of $2.60-$3.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.22.
What price target have analysts set for CC?
12 analysts have issued 12 month price objectives for Chemours' shares. Their forecasts range from $14.50 to $42.00. On average, they expect Chemours' share price to reach $23.15 in the next twelve months. This suggests a possible upside of 19.5% from the stock's current price. View Analyst Price Targets for Chemours.
What is the consensus analysts' recommendation for Chemours?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 7 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemours.
Has Chemours been receiving favorable news coverage?
News headlines about CC stock have trended somewhat positive recently, InfoTrie reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Chemours earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned news coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Chemours.
Are investors shorting Chemours?
Chemours saw a drop in short interest in the month of January. As of January 31st, there was short interest totalling 14,520,000 shares, a drop of 11.3% from the January 15th total of 16,370,000 shares. Based on an average daily trading volume, of 2,610,000 shares, the short-interest ratio is presently 5.6 days. Currently, 9.0% of the company's stock are sold short. View Chemours' Current Options Chain.
What other stocks do shareholders of Chemours own?
Who are Chemours' key executives?
Chemours' management team includes the folowing people:
- Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
- Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
- Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
- Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
- Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)
Who are Chemours' major shareholders?
Chemours' stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (14.54%), LSV Asset Management (2.53%), State Street Corp (2.42%), Bank of New York Mellon Corp (1.95%), Charles Schwab Investment Management Inc. (0.84%) and Connor Clark & Lunn Investment Management Ltd. (0.60%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.
Which institutional investors are selling Chemours stock?
CC stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Connor Clark & Lunn Investment Management Ltd., W.E. Donoghue & Co. LLC, Envestnet Asset Management Inc., Robeco Institutional Asset Management B.V., NEXT Financial Group Inc, Acadian Asset Management LLC and Atria Investments LLC. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman, Mark P Vergnano and Paul Kirsch. View Insider Buying and Selling for Chemours.
Which institutional investors are buying Chemours stock?
CC stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, Great Lakes Advisors LLC, Bank of New York Mellon Corp, First Trust Advisors LP, Anavon Capital LLP, Blackcrane Capital LLC, DT Investment Partners LLC and UBS Asset Management Americas Inc.. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.
How do I buy shares of Chemours?
Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Chemours' stock price today?
One share of CC stock can currently be purchased for approximately $19.37.
MarketBeat Community Rating for Chemours (NYSE CC)
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
